Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 1138 for “"Aβ"”.
-
The impact of adult neurogenesis on Aβ plaques, Aβ seeding and spreading
… decline, and the accumulation of amyloid-β (Aβ) peptides, ultimately leading to plaque formation and neuronal degeneration. Although impaired adult neurogenesis has been reported in both AD patients and transgenic mouse models, it remains unclear whether this reduction is a consequence of Aβ …
-
Endocannabinoids as Amyloid-Beta (Aβ) Aggregation Inhibitors
… Alzheimer's disease, which is characterized by Aβ aggregation-induced cell toxicity, inflammation, tau phosphorylation, disruption of neurotransmitters pathways, mitochondrial dysfunction, and oxidative stress. The endocannabinoids, such as 2-AG, AEA, NADA, noladin, OAE, and their main …
-
Stimulators of Aβ aggregation identified through drug screening
<p>Alzheimer's disease (AD) is a neurodegenerative disorder characterized by extensive deposition of amyloid plaques in the brain. These plaques contain an amyloid fibril core that is formed through self-aggregation of the P-amyloid peptide (AP), a proteolytic product of amyloid precursor protein …
-
Substratdimerisierung und Aβ-Produktion im γ-Sekretase-Komplex
Das toxische Aβ42-Peptid gilt als kausatives Agens der Alzheimer-Krankheit. Es wird von der γ-Sekretase durch sukzessive Schnitte aus dem Vorläufermolekül APP-CTF (C-terminales Fragment des Amyloidvorläuferproteins) produziert. Die Dimerisierung des APP-CTFs über die GxxxG-Motive in seiner …
-
Nicotinic acetylcholine receptors and their interaction with Aβ₁₋₄₂
Alzheimer's Disease (AD) is a progressive, age-related disease that is positively characterised by the post-mortem presence of neurofibrillary tangles and amyloid plaques. At present ~ 5 % of those aged over 65 years are diagnosed with AD, with this figure increasing to ~ 20 % for those aged over …
-
Regulation of APP processing and Aβ production by BACE1
… plaques in the brain. Amyloid β protein (Aβ), a peptide of 39–42 amino acids, forms the predominant component of plaques. Aβ is generated from amyloid-β precursor protein (APP) by sequential cleavages mediated by β-secretase and γ-secretase. Previous studies have shown that BACE1 can …
-
Piperine Derivatives as Modulators of Amyloid-Beta (Aβ) Aggregation
… the aggregation of a protein known as amyloid-β (Aβ). However, most pharmacotherapies for AD provide only symptomatic relief and target other pathways. The recently approved monoclonal antibodies (mAbs) are the only disease-modifying therapies targeting Aβ peptide aggregation in AD that are …
-
Characterization of Aβ Aggregates Using Hydrogen/Deuterium Exchange Mass Spectrometry
… the hydrogen-bonding interaction sites within Aβ aggregates associated with Alzheimer’s disease using hydrogen/deuterium exchange mass spectrometry (HDX-MS) coupled with proteolysis. Toward this end, an on-line digestion system utilizing a triaxial electrospray probe as the front end to MS was …
-
Novel 1,4-Diazepane Derivatives as Amyloid Beta (Aβ) Aggregation Inhibitors
… driven by the accumulation of amyloid-β (Aβ) plaques and tau tangles in the brain. The Aβ aggregation is indeed the primary pathological event, playing a key role in the initiation and progression of the disease. Despite extensive research, effective disease-modifying treatments remain …
-
Charakterisierung eines Dimerisierungsmotivs in der Aβ-Region des Amyloid- Vorläuferproteins
Das Aβ-Peptid mit 42 Resten (Aβ42) führt zur neuronalen Degeneration als Ursache der Alzheimer Krankheit. Es entsteht durch die Prozessierung des Amyloid-Vorläuferproteins (APP) durch die β- und g-Sekretasen. Neben Aβ42 werden auch weitere Aβ-Spezies unterschiedlicher Länge gebildet. APP kann über …
-
Aβ-driven cellular pathology in human neuronal models of Alzheimer's disease
Alzheimer’s disease (AD) is an insidious age-related neurodegenerative disease and the most common type of dementia. AD neuropathology typically involves the accumulation of extracellular plaques as well as intracellular neurofibrillary tangles that mainly consist of amyloid-beta (Abeta) and …
-
Yeast as a Model for Studying Aβ Aggregation, Toxicity and Clearance
… of these amyloid deposits is the amyloid beta (Aβ) protein. The Aβ protein is a 40 or 42 amino acid cleavage product of APP (Amyloid Precursor Protein) which is produced in low levels in the normal ageing brain. Although senile amyloid plaques is the major pathological hallmark of AD brains, …
-
The Effects of Calpain on the Degradation of Amyloid Beta (Aβ) Protein
… could contribute to the abnormal accumulation of Aβ in the brain: over production and/or failure in clearance of this A-beta peptide. In an effort to identify the cellular system that is involved in A-beta clearance, we conducted experiments to investigate the effects of calpain inhibitors on the …
-
An investigation of amyloid (Aβ) induced pathology in age-related macular degeneration
… aggregates in early AMD. Amyloid beta (Aβ), a highly toxic and penetrative peptide associated with Alzheimer’s disease, has also been shown to deposit in the ageing retina and associated with key stages of AMD. The purpose of this work was to elucidate the association of Aβ with AMD …
-
Sterol Transport Protein ORP6 Regulates Astrocytic Cholesterol Metabolism and Brain Aβ Deposition
… and whole-body lipid homeostasis, increased Aβ deposition in the brain and neuroanatomical alterations. Together, our findings highlight a critical role for cholesterol trafficking proteins in brain cholesterol homeostasis and identify ORP6 as a potential novel target for AD.
Page 1 of 57